Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAT severe asthma
ISRCTN57935812Phase 2Completed
- Sponsor
- University of Leicester
- Start
- Aug 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of dexpramipexole and doxycycline in severe asthma (4 arms), sponsored by University of Leicester. Primary endpoint: Annual rate of severe exacerbations. Started Aug 2021; status: completed.
02
Drugs
dexpramipexoledoxycycline
03
Conditions
severe asthma
Beyond the preview
Go deeper on ISRCTN57935812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57935812.